FAM
CNTA

Fred Alger Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Fred Alger Management’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.68M Buy
168,170
+6,023
+4% +$154K 0.03% 203
2025
Q4 		$4.06M Sell
162,147
-28,213
-15% -$715K 0.02% 262
2025
Q3 		$4.62M Buy
190,360
+66,604
+54% +$1.18M 0.02% 246
2025
Q2 		$1.63M Sell
123,756
-22,642
-15% -$287K 0.01% 326
2025
Q1 		$2.11M Sell
146,398
-44,053
-23% -$721K 0.01% 295
2024
Q4 		$3.19M Buy
190,451
+12,898
+7% +$214K 0.02% 286
2024
Q3 		$2.84M Buy
177,553
+166,560
+1,515% +$2.04M 0.01% 300
2024
Q2 		$99.3K Buy
+10,993
New +$104K ﹤0.01% 402

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fred Alger Management's CNTA Position: Q1 2026 in Review

Fred Alger Management increased its Centessa Pharmaceuticals (CNTA) stake by 3.7% in Q1 2026, buying an estimated $154K and bringing the position to 168,170 shares worth $6.68M. The position accounts for 0.03% of the portfolio, ranked #203.

Fred Alger Management first reported a position in CNTA in Q2 2024 and has held it in 8 quarters since. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Fred Alger Management held 168,170 shares of Centessa Pharmaceuticals worth $6.68M as of Q1 2026.
  • Fred Alger Management bought 6,023 Centessa Pharmaceuticals shares in Q1 2026, an estimated $154K.
  • Centessa Pharmaceuticals made up 0.03% of Fred Alger Management's portfolio in Q1 2026, its #203 holding.
  • Fred Alger Management first reported a position in Centessa Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.